Published: 11/24/2021 03:37 GMT Outlook Therapeutics Inc (OTLK) - Reases Previously Announced Bought Deal Offering of Common Stock to $50 Million.
Underwriter Has Agreed to Purchase 40 Million Shares of Stock of Co at a Price to Public of $1.25 per Share.